PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
16-Jun-2025 Veranova Announces Strategic Investment to Establish cGMP Bioconjugation Capability in Devens, MA Veranova
16-Jun-2025 Alfa Chemistry Expands Its Portfolio with the Release of Dozens of Pyrrole Alkaloids Alfa Chemistry
16-Jun-2025 Alfa Chemistry Expands Portfolio with High-Quality Ion Exchange Resins and Chromatography Media for Enhanced Purification and Separation Alfa Chemistry
14-Jun-2025 Jetbio rolls out miniReJI 3D Bioprinters for printing of cancer cell models Jetbio Ltd
13-Jun-2025 Datalogic and B. Braun enable safer oncology treatment with Memor™ 17 Healthcare Certification for OncoSafety Remote Control® datalogic
12-Jun-2025 UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity UCB
12-Jun-2025 Accelerate@Babraham 2025 announces new cohort Babraham
12-Jun-2025 AlzeCure receives positive FDA response regarding Phase II/III studies with ACD440 in a rare disease AlzeCure
12-Jun-2025 Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison Johnson & Johnson
12-Jun-2025 Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR Levicept
12-Jun-2025 Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma Enterome
12-Jun-2025 AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors AstriVax Therapeutics
12-Jun-2025 Oxeltis and Molecular Forecaster forge strategic collaboration to enhance client’s drug design and synthesis Andrew Lloyd Associates
11-Jun-2025 Biomunex Pharmaceuticals appoints its new Scientific Advisory Board on MAIT, composed of MAIT cell experts to accelerate the development of its MAIT engagers in immuno-oncology Biomunex Pharmaceuticals
11-Jun-2025 Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD Outlook Therapeutics
11-Jun-2025 SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines SpliceBio
11-Jun-2025 Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders Angelini Ventures
11-Jun-2025 Northern Gritstone invests in Manchester spinout Apini Northern Gritstone
11-Jun-2025 Rare disease biotech announces ‘hugely significant’ milestone with selection of candidate drug SynaptixBio
11-Jun-2025 ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care Novo Nordisk